
Explore an innovative Graph Neural Network approach for drug discovery, incorporating molecular chirality and offering interpretable results to enhance quantitative structure-activity relationship modeling.

Explore CETSA's role in target engagement and mode of action deconvolution, focusing on cell background impact and mass spectrometry coupling for small compound analysis.

Explore genetically modified cell models for drug discovery, focusing on protein stabilization and DUBTAC approaches. Learn how engineered cell lines accelerate therapeutic development and enable disease modeling.

Explore innovative Human-on-a-Chip systems for drug discovery, focusing on their application in therapeutic index determination and systemic toxicity assessment in pre-clinical stages.

Explore neural network potentials for efficient 3D structure generation and reactivity prediction in molecular modeling, featuring Auto3D package and ANI-2xt model advancements.

Explore molecule representation learning through topology, geometry, and textual description. Gain insights into AI-driven drug discovery and molecular modeling techniques.

Explore ProtMD, a novel approach incorporating protein flexibility in drug binding predictions using molecular dynamics simulations and self-supervised learning techniques for improved accuracy.

Explore DiffDock, a novel diffusion-based approach to molecular docking that outperforms traditional and deep learning methods in predicting ligand-protein binding structures for drug design.

Explore equivariant 3D-conditional diffusion models for molecular linker design in drug discovery. Learn about DiffLinker's innovative approach to connecting multiple fragments and its applications in real-world scenarios.

Explore single-cell perturbation response prediction for novel drugs using an encoder-decoder architecture and transfer learning, enhancing drug discovery efficiency through in-silico hypothesis generation.

Explore fluorescence microscopy techniques for cancer research, covering cell staining, imaging methods, and applications in drug discovery and mechanism studies for 2D and 3D models.

Explore new methods and technologies accelerating sequence-based screening of plasmids for discovery, research, and biotechnology. Learn about ExpressPlex technology and its integration with rolling-circle amplification in OCTOPUS v3.0.

Explore high-throughput DESI-MS for drug discovery, including reaction screening, nano-scale synthesis, and bioanalysis. Learn innovative techniques for faster compound library synthesis and bioactivity assessment.

Explore molecular glues targeting 14-3-3 protein interactions to modulate MAPK pathway and C-RAF activity in cancer networks. Gain insights into innovative approaches for potential cancer therapies.

Explore self-driving laboratories revolutionizing scientific discovery through AI and automation. Learn about cutting-edge applications, key elements, and opportunities in chemistry, materials science, and biotechnology.

Explore advanced neural network interatomic potentials for molecular dynamics simulations using Stability-Aware Boltzmann Estimator Training to enhance stability and accuracy across various systems and architectures.

Explore PDGRAPHER, a novel graph neural network model for phenotype-driven drug discovery. Learn how it predicts perturbagens to reverse disease effects, offering faster and more efficient therapeutic target identification.

Explore HyperPCM, a robust method for predicting drug-target interactions using hypernetworks. Learn about its state-of-the-art performance on benchmarks and excellence in zero-shot inference for unseen protein targets.

Explore MFBind, a multi-fidelity approach integrating docking and binding free energy simulations for improved drug discovery generative modeling. Learn its advantages over current methods.

Explore advancements in synthesis planning evaluation through syntheseus and retro-fallback, enhancing molecule discovery with probabilistic uncertainty and new search algorithms.

Explore InfoCORE, an innovative approach to remove batch effects in drug screening data, enhancing molecular representations for improved property prediction and molecule-phenotype retrieval.